These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16707778)

  • 1. Defining and assessing adherence to oral antipsychotics: a review of the literature.
    Velligan DI; Lam YW; Glahn DC; Barrett JA; Maples NJ; Ereshefsky L; Miller AL
    Schizophr Bull; 2006 Oct; 32(4):724-42. PubMed ID: 16707778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
    Velligan DI; Wang M; Diamond P; Glahn DC; Castillo D; Bendle S; Lam YW; Ereshefsky L; Miller AL
    Psychiatr Serv; 2007 Sep; 58(9):1187-92. PubMed ID: 17766564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments, and prospects.
    Young JL; Spitz RT; Hillbrand M; Daneri G
    J Am Acad Psychiatry Law; 1999; 27(3):426-44. PubMed ID: 10509942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
    Dolder CR; Lacro JP; Dunn LB; Jeste DV
    Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
    Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
    J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Velligan DI; Maples NJ; Pokorny JJ; Wright C
    Schizophr Res; 2020 Jan; 215():17-24. PubMed ID: 31767511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Consensus Recommendations for Urine Testing of Adherence to Antipsychotics Among People With Serious Mental Illness.
    Cohen AN; Collins G; Nucifora FC; Strobel R; Wait DB; Young AS
    Psychiatr Serv; 2018 Mar; 69(3):345-348. PubMed ID: 29241434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.
    Hong J; Novick D; Brugnoli R; Bertsch J; Haro JM
    Hum Psychopharmacol; 2013 Sep; 28(5):438-46. PubMed ID: 23775950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
    Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
    Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
    Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis.
    Yaegashi H; Kirino S; Remington G; Misawa F; Takeuchi H
    CNS Drugs; 2020 Jun; 34(6):579-598. PubMed ID: 32219681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.